StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
RKDAArcadia Biosciences, Inc.
stockpulse.co.kr
Nasdaq
$0.1505▼ 5.82%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $328,348.11Shares out 2.2M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

11
  • 9.30After-hours26.10.01 05:13
    S-8Offering#●●●

    Arcadia Biosciences, Inc.

    Arcadia Biosciences, Inc. has registered 400,000 shares of its common stock to be issued under the '2026 Omnibus Equity Incentive Plan,' which was approved by stockholders on September 10, 2026. This registration is intended to facilitate equity-based compensation for employees and other eligible participants.…more

    $0.1505-5.82%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.30Pre-market26.09.30 21:26
    SCHEDULE 13GOwnership

    Arcadia Biosciences, Inc.

    MJL Manager LLC has filed a Schedule 13G, disclosing its acquisition of a stake in Arcadia Biosciences, Inc. This filing officially confirms the substantial share ownership of the company by MJL Manager LLC.…more

    $0.1505-5.82%vs prev close
    View filingShare
  • 9.15Regular26.09.16 04:01
    8-KKey event

    Arcadia Biosciences, Inc.

    Arcadia Biosciences held its 2026 Annual Meeting of Stockholders on September 10, 2026, approving the 2026 Omnibus Equity Incentive Plan and ratifying director elections and executive compensation. Additionally, stockholders authorized the Board of Directors to effect a reverse stock split at a ratio between 1-for-2 and 1-for-10 at any time before June 30, 2027.…more

    $0.1505-5.82%vs prev close
    View filingShare

10 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.30Pre-market26.09.30 21:32
    #●●●

    Arcadia Biosciences: MJL Manager Discloses 15.7% Stake

    According to a recent SEC filing, MJL Manager has reported a 15.7% stake in Arcadia Biosciences as of August 13. This disclosure of a significant ownership position may attract investor attention.…more

    $0.1505-5.82%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga